BAUDETTE, Minn. (AP) — BAUDETTE, Minn. (AP) — ANI Pharmaceuticals Inc. (ANIP) on Friday reported third-quarter net income of $26.6 million, after reporting a loss in the same period a year earlier.
The Baudette, Minnesota-based company said it had net income of $1.13 per share. Earnings, adjusted for one-time gains and costs, were $2.04 per share.
The results exceeded Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of $1.74 per share.
The drugmaker posted revenue of $227.8 million in the period, which also beat Street forecasts. Six analysts surveyed by Zacks expected $211.3 million.
ANI expects full-year revenue in the range of $854 million to $873 million.
ANI shares have risen 63% since the beginning of the year. The stock has risen 55% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ANIP at https://www.zacks.com/ap/ANIP
/A%20Lucid%20Motors%20vehicle%20parked%20in%20front%20of%20a%20showroom_%20Image%20by%20Michael%20Berlfein%20via%20Shutterstock_.jpg)
/Broadcom%20Inc%20logo%20on%20phone%20and%20site-by%20Majahid%20Mottakin%20via%20Shutterstock.jpg)
/Tesla%20Inc%20logo%20by-%20baileystock%20via%20iStock.jpg)
